Navigation Links
Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008
Date:11/13/2008

Breakthrough Innovation Gives Greater Numbers of Pharmaceutical Scientists Access to the Power of the Xevo TQ System's Quantitative and Qualitative

Capabilities

MILFORD, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Focused on the process of helping firms to move promising drug candidates into commercialization, Waters Corporation (NYSE: WAT) will showcase innovative UltraPerformance LC(R) (UPLC) and mass spectrometry (MS) solutions at the American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS), November 16 - 20 in Atlanta, Georgia.

With the cost of developing and commercializing new drugs at an all-time high, there is an acute need for versatile and multitasking analytical instruments that can automate routine tasks and obtain more analytical data faster with a minimum of effort. Waters(R) goal is to allow pharmaceutical scientists to devote more precious time to value-added, problem-solving activities that lie at the heart of the drug discovery process.

Leading Waters' offerings at AAPS is the Xevo(TM) TQ MS System, an advanced tandem quadrupole mass spectrometer that allows more pharmaceutical scientists across disciplines to quickly assess the candidacy of promising new entities. Aided by the instrument's IntelliStart(TM) and ScanWave(TM) technologies, the Xevo TQ MS System produces high-quality mass spectral data at UPLC(R) acquisition speeds without sacrificing data quality. With tools like the Xevo TQ MS System, increases in information per unit of time -- and in the value of that information -- promise to greatly enhance efforts to "industrialize" the process of drug discovery on a global basis.

Waters Scientific Seminars at AAPS

Waters UPLC and MS technologies have set new standards in resolution, sensitivity and speed of analysis. To demonstrate these capabilities, Waters will host one-hour educational seminars in Hall 4C, Aisle 100, on the following topics:

-- Developing Robust Quantitative Bioanalysis Methods with Innovations in

SPE and LC/MS/MS

-- High-Sensitivity Qualitative and Quantitative LC/MS: New Possibilities

with an Easy-to use Tandem Quadrupole Mass Spectrometer

-- An Introduction to UPLC Technology

-- An Intelligent UPLC/TOF MS Workflow for Metabolite Identification

-- A Simple, Strategic Approach to Method Development

-- Maximizing Sensitivity and Flexibility in a Bioanalytical Assay with

UPLC/MS

Earlier this year the Xevo TQ MS System was recognized by Strategic Directions International's Instrument Business Outlook (IBO) newsletter when it selected the Xevo TQ MS System as the Best New Product at the 2008 American Society of Mass Spectrometry (ASMS) annual meeting in June: http://tinyurl.com/5wfehx.

"Since introducing the Xevo TQ MS System four months ago, the feedback we have received through customer demos has been outstanding," said Brian Smith, Vice President of Mass Spectrometry for the Waters Division. "Ranging from the impact of an 'intelligent' tandem quadrupole MS that automatically performs all those time consuming optimization steps normally performed manually by a skilled MS operator to the novel ScanWave technology that significantly enhances the quality of spectral data, mass spectrometer users at all levels are seeing the potential that the Xevo TQ MS System could bring to their laboratory."

Waters is now shipping the Xevo TQ MS System to customers on a worldwide basis.

For More Information

More information on Waters products at AAPS including the Synapt(TM) MS System and ACQUITY(R) UPLC System, visit Waters booth #2731 or go to: http://www.waters.com/aaps. For information on the new Xevo TQ MS System visit http://www.waters.com/xevo. For more information on Waters portfolio of LC/MS products, please visit: http://www.waters.com/ms.

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, Xevo, UltraPerformance LC, UPLC, ACQUITY, Synapt, ScanWave, and IntelliStart are trademarks of Waters Corporation.

Contact:

Brian J. Murphy

Waters Corporation

Public Relations Manager

508-482-2614

Brian_J_Murphy@waters.com


'/>"/>
SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Waters SYNAPT HDMS and Xevo TQ MS Recognized for Mass Spectrometry Innovation by Industry Experts
2. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
3. Waters Offers U.S. Water Authorities Complimentary Drinking Water Testing for the Presence of Pharmaceuticals
4. Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008
5. Vanderbilt University Medical Center and Waters Collaborate on Tissue Imaging Research Using SYNAPT HDMS
6. 2007: A Watershed Year for Lupus Research and Education
7. Extracts of catfish caught in polluted waters cause breast cancer cells to multiply
8. Waters Corporation Receives Market Leadership and Product Innovation Awards
9. Out of the woods: Physicians get urban disaster training in forests, gorges and waters
10. Cleveland Clinic Unveils Top 10 Medical Innovations for 2009
11. Coromega Unveils New Healthy Heart and CoQ10 Supplements : Revolutionary Omega-3 Supplement Company Introduces Two Fresh Takes on Heart Health and Antioxidants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology: